12/12/2017 |
BASi Announces Enhanced Bioequivalence Capabilities
|
11/13/2017 |
Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
|
10/03/2017 |
Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of In Vivo Products and Services
|
09/19/2017 |
BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
|
09/06/2017 |
BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
|
08/28/2017 |
BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design
|
08/03/2017 |
BASi Announces Election of R. Matthew Neff to the Board of Directors
|
07/31/2017 |
BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex® Automated Blood Sampling Systems
|
06/27/2017 |
BASi Completes Refinancing of Senior Secured Credit Facilities
|
06/20/2017 |
BASi Names Dr. Gregory C. Davis to Board of Directors
|
06/07/2017 |
BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data
|
05/01/2017 |
BASi Announces Appointment of Dr. Peter T. Kissinger as Scientific Advisor
|
03/08/2017 |
BASi Names Philip Downing Senior Vice President of Preclinical Services
|